Campagna Jason
Chief Medical Officer at INTERCEPT PHARMACEUTICALS INC
- Sold, on record
- $158k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Aug 18, 2020
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- INTERCEPT PHARMACEUTICALS INCChief Medical Officer
Sales by reason
0
Routine
3
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Aug 18, 2020Plan not stated
Sold 12% of their holdings
$57k1,192 shares at $47.44
- Jan 7, 2020Plan not stated
Sold 10.4% of their holdings
$83k732 shares at $113.02
- Dec 19, 2019Plan not stated
Sold 2% of their holdings
$18k154 shares at $119.45
3 of 3
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | Feb 26, 2025 | QTTB | Chief Medical Officer | Returned to the companyStock Option (Right to Buy) | 176,376 | 0 | SEC | ||
| Feb 24, 2025 | Feb 26, 2025 | QTTB | Chief Medical Officer | AwardedStock Option (Right to Buy) | 176,376 | 70,687 | SEC | ||
| Feb 24, 2025 | Feb 26, 2025 | QTTB | Chief Medical Officer | Awarded | 37,500 | 37,500 | SEC | ||
| Mar 25, 2024 | Mar 27, 2024 | QTTB | Chief Medical Officer | AwardedStock Option (Right to Buy) | 70,687 | 70,687 | SEC | ||
| Jan 22, 2021 | Jan 26, 2021 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | AwardedOption to Purchase Common Stock | 19,700 | 19,700 | SEC | ||
| Jan 22, 2021 | Jan 26, 2021 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Awarded | 12,600 | 20,531 | SEC | ||
| Jan 1, 2021 | Jan 5, 2021 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 666 | $24.70 | $16k | 7,931 | SEC |
| Oct 1, 2020 | Oct 5, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 112 | $42.08 | $5k | 8,597 | SEC |
| Sep 15, 2020 | Sep 17, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 69 | $43.41 | $3k | 8,709 | SEC |
| Aug 18, 2020 | Aug 20, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Sold | 1,192 | $47.44 | $57k | 8,778 | SEC |
| Jul 1, 2020 | Jul 6, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 112 | $46.52 | $5k | 9,970 | SEC |
| Jun 15, 2020 | Jun 17, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 70 | $77.40 | $5k | 10,082 | SEC |
| Apr 1, 2020 | Apr 3, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 112 | $58.40 | $7k | 10,152 | SEC |
| Mar 15, 2020 | Mar 17, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 69 | $71.82 | $5k | 10,264 | SEC |
| Feb 19, 2020 | Feb 21, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 170 | $96.24 | $16k | 10,333 | SEC |
| Jan 23, 2020 | Jan 27, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | AwardedOption to Purchase Common Stock | 6,900 | 6,900 | SEC | ||
| Jan 23, 2020 | Jan 27, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Awarded | 4,200 | 10,503 | SEC | ||
| Jan 7, 2020 | Jan 8, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Sold | 732 | $113.02 | $83k | 6,303 | SEC |
| Jan 1, 2020 | Jan 3, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 409 | $123.92 | $51k | 7,035 | SEC |
| Dec 19, 2019 | Dec 20, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Sold | 154 | $119.45 | $18k | 7,444 | SEC |
| Dec 15, 2019 | Dec 17, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Withheld for tax | 80 | $114.16 | $9k | 7,598 | SEC |
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | Aug 20, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 1,192 | $57k | 12.0% | Plan not stated | SEC |
| Jan 7, 2020 | Jan 8, 2020 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 732 | $83k | 10.4% | Plan not stated | SEC |
| Dec 19, 2019 | Dec 20, 2019 | INTERCEPT PHARMACEUTICALS INC | Chief Medical Officer | Form 4 sale | 154 | $18k | 2.0% | Plan not stated | SEC |